Direct-to-Consumer Marketing of Genetic Testing

Number 409

Professional Liability and Gynecology-Only Practice

Number 408

(Reaffirmed 2012, Replaces No. 288, October 2003)

Late-Preterm Infants

Number 404

(Reaffirmed 2011)

End-of-Life Decision Making

Number 403

Surrogate Motherhood

Number 397

Umbilical Cord Blood Banking

Number 399

(Reaffirmed 2012, Replaces No. 183, April 1997)

Intraperitoneal Chemotherapy for Ovarian Cancer

Number 396

(Reaffirmed 2010 )

Surgery and Patient Choice

Number 395

Ethical Decision Making in Obstetrics and Gynecology

Number 390

(Reaffirmed 2010)

Human Immunodeficiency Virus

Number 389

Supracervical Hysterectomy

Number 388

(Reaffirmed 2010)

The Limits of Conscientious Refusal in Reproductive Medicine

Number 385

(Reaffirmed 2010)

Fetal Monitoring Prior to Scheduled Cesarean Delivery

Number 382

(Reaffirmed 2010)

Subclinical Hypothyroidism in Pregnancy

Number 381

(Reaffirmed 2012)

Management of Delivery of a Newborn With Meconium-Stained Amniotic Fluid

Number 379

(Reaffirmed 2010)

Vaginal "Rejuvenation" and Cosmetic Vaginal Procedures

Number 378

Research Involving Women

Number 377

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Number 376

(Reaffirmed 2012)

Brand Versus Generic Oral Contraceptives

Number 375

(Reaffirmed 2010)

Expert Testimony

Number 374

(Reaffirmed 2010)